[17] The status has since remained unsettled rather than resolved in the compounds favor: in 2026 the nomination behind that listing was withdrawn and BPC-157 was removed from Category 2, yet the FDA did not move it to the permitted (Category 1) list, and at its July 2026 Pharmacy Compounding Advisory Committee review the agency proposed against adding BPC-157 to the 503A bulk-substances list at all

When symptoms are attributed to high B12 intake, they typically include: Skin reactions : Acne-like eruptions or rosacea-type rashes, particularly with hydroxocobalamin injections (listed as rare adverse effects in the product information) Gastrointestinal disturbances : Mild nausea, diarrhoea, or abdominal discomfort Headaches : Occasional reports of headache following B12 injections Anxiety or restlessness : Anecdotal reports, though causation remains unestablished It is crucial to distinguish between symptoms caused by elevated B12 levels and those arising from the underlying conditions that elevate B12
Vitamin B12 is a water-soluble vitamin, meaning the body excretes any excess through urine rather than storing it
The first 8 weeks were great
An unrelated illness at the same time A B12 injection does not protect you from catching something else that week
With respect to inflammatory phenotype, the present cytokine analysis should be interpreted with caution